Invitation

Dear Colleagues,

It is with great pleasure that the American Association for the Study of Liver Diseases (AASLD) and the Turkish Association for the Study of the Liver (TASL) announce our third joint conference to CONNECT physicians and health care providers in Turkey with experts from the USA and Turkey in hepatology.

This year, we continue to innovate our program with a goal to provide a seamless, productive interactive experience for our attendees and to create collaborative opportunities for members of TASL and AASLD. Thus, we offer attendees in our joint AASLD-TASL Digital Hepatology Connect to also register (at no additional cost) for The Liver Meeting Digital Experience™ 2021.

This is similar to the arrangement we made last year, which was extremely well received. Attendees will learn about the latest liver disease research being presented at The Liver Meeting Digital Experience,™ followed, with the Hepatology Connect, by the new information brought to life with case study-based discussions about the diagnosis and management of major liver diseases including viral hepatitis, hepatocellular carcinoma, fatty liver, cirrhosis and liver transplantation. The opportunity to interact with the large number of AASLD faculty and with local and regional experts in the science and practice of hepatology will make this a must-attend combination of events for the audience from Turkey and the surrounding region.

We would be grateful to partner with organizations and companies that share our vision of collaboration and exchange. Support of this meeting is vital so that we can provide attendees with a quality meeting experience. Specifically, your support will help us deliver an exceptional scientific program via a digital platform that allows for large didactic lectures and smaller breakout sessions, as well as other opportunities for faculty and attendees to interact. Your participation will be mutually beneficial. There will be opportunities for satellite symposia and virtual exhibition space, and your involvement will provide exposure and brand recognition to extend your reach to hundreds of attendees.

On behalf of AASLD and TASL, we would like to thank you in advance for your financial contribution. Your support will play a crucial role in promoting liver health, providing quality patient care, and advancing the study and practice of hepatology in the region, especially in the area of viral hepatitis, chronic liver disease and hepatocellular carcinoma. It is because of supporters like you that we are able to plan and implement programs of this magnitude and collaboration on a global level. Your generosity directly allows us to carry out our mission to prevent and ultimately cure liver disease in Turkey, the US, and the world over.

Sincerely,

W. Ray Kim, MD

Councilor and Governing Board Liaison, AASLD

Co-organizer, AASLD-TASL Connect

Ramazan Idilman, MD

President, TASL

Co-organizer, AASLD-TASL Connect


Murat Akyıldız, MD